BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report) shares were up 4.5% on Tuesday . The stock traded as high as $1.90 and last traded at $1.85. Approximately 13,494 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 87,537 shares. The stock had previously closed at $1.77.
BeyondSpring Price Performance
The firm has a 50-day moving average price of $2.13 and a two-hundred day moving average price of $2.23.
Institutional Investors Weigh In On BeyondSpring
A hedge fund recently bought a new stake in BeyondSpring stock. SG Americas Securities LLC acquired a new stake in BeyondSpring Inc. (NASDAQ:BYSI – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 17,539 shares of the company’s stock, valued at approximately $63,000. Hedge funds and other institutional investors own 40.29% of the company’s stock.
About BeyondSpring
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Recommended Stories
- Five stocks we like better than BeyondSpring
- What is the Australian Securities Exchange (ASX)
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- 3 Grocery Stocks That Are Proving They Are Still Essential
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Do S&P 500 Stocks Tell Investors About the Market?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
